Schweitzer KJ - Search Results

1

Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.

Schweitzer KJ, Hilker R, Walter U, Burghaus L, Berg D. Schweitzer KJ, et al. Mov Disord. 2006 Jan;21(1):94-8. doi: 10.1002/mds.20669. Mov Disord. 2006. PMID: 16114024

2

Multiregional brain iron deficiency in restless legs syndrome.

Godau J, Klose U, Di Santo A, Schweitzer K, Berg D. Godau J, et al. Mov Disord. 2008 Jun 15;23(8):1184-7. doi: 10.1002/mds.22070. Mov Disord. 2008. PMID: 18442125

3

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.

Berg D, Seppi K, Liepelt I, Schweitzer K, Wollenweber F, Wolf B, Dillmann U, Stockner H, Godau J, Kiechl S, Gaenslen A, Willeit J, Di Santo A, Maetzler W, Gasser T, Poewe W, Behnke S. Berg D, et al. Mov Disord. 2010 Jul 30;25(10):1464-9. doi: 10.1002/mds.23114. Mov Disord. 2010. PMID: 20629151

4

Predictive value of transcranial sonography in the diagnosis of Parkinson's disease.

Prestel J, Schweitzer KJ, Hofer A, Gasser T, Berg D. Prestel J, et al. Among authors: schweitzer kj. Mov Disord. 2006 Oct;21(10):1763-5. doi: 10.1002/mds.21054. Mov Disord. 2006. PMID: 16874758 Clinical Trial.

5

Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome.

Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D. Godau J, et al. Among authors: schweitzer kj. Mov Disord. 2007 Jan 15;22(2):187-92. doi: 10.1002/mds.21230. Mov Disord. 2007. PMID: 17133515

6

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.

Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D. Gaenslen A, et al. Among authors: schweitzer kj. Lancet Neurol. 2008 May;7(5):417-24. doi: 10.1016/S1474-4422(08)70067-X. Epub 2008 Apr 3. Lancet Neurol. 2008. PMID: 18394965 Clinical Trial.

7

Enlarged substantia nigra hyperechogenicity and risk for Parkinson disease: a 37-month 3-center study of 1847 older persons.

Berg D, Seppi K, Behnke S, Liepelt I, Schweitzer K, Stockner H, Wollenweber F, Gaenslen A, Mahlknecht P, Spiegel J, Godau J, Huber H, Srulijes K, Kiechl S, Bentele M, Gasperi A, Schubert T, Hiry T, Probst M, Schneider V, Klenk J, Sawires M, Willeit J, Maetzler W, Fassbender K, Gasser T, Poewe W. Berg D, et al. Arch Neurol. 2011 Jul;68(7):932-7. doi: 10.1001/archneurol.2011.141. Arch Neurol. 2011. PMID: 21747034

8

Cross-sectional study discloses a positive family history for Parkinson's disease and male gender as epidemiological risk factors for substantia nigra hyperechogenicity.

Schweitzer KJ, Behnke S, Liepelt I, Wolf B, Grosser C, Godau J, Gaenslen A, Bruessel T, Wendt A, Abel F, Müller A, Gasser T, Berg D. Schweitzer KJ, et al. J Neural Transm (Vienna). 2007 Sep;114(9):1167-71. doi: 10.1007/s00702-007-0725-5. Epub 2007 Apr 20. J Neural Transm (Vienna). 2007. PMID: 17446999

9

Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.

Berg D, Hochstrasser H, Schweitzer KJ, Riess O. Berg D, et al. Among authors: schweitzer kj. Neurotox Res. 2006 Jan;9(1):1-13. doi: 10.1007/BF03033302. Neurotox Res. 2006. PMID: 16464747 Review.

10

Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.

Schweitzer KJ, Brüssel T, Leitner P, Krüger R, Bauer P, Woitalla D, Tomiuk J, Gasser T, Berg D. Schweitzer KJ, et al. J Neurol. 2007 May;254(5):613-6. doi: 10.1007/s00415-006-0369-7. Epub 2007 Apr 6. J Neurol. 2007. PMID: 17415511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters